Sale!

ARA-290 10mg

Original price was: $34.99.Current price is: $29.99.

Free Shipping on Orders Over $150

Key Research Areas (Preclinical Use Only)

ARA-290 is under investigation in in vitro and animal models in the following research domains:

  • Metabolic Studies: Evaluated for effects on glucose regulation and lipid profiles

  • Neuropathic Pain Models: Studied for modulation of pain signaling pathways in experimental neuropathy

  • Inflammatory Regulation: Explored for anti-inflammatory signaling via TPR interaction

  • Tissue Repair & Wound Healing: Assessed in models of skin and soft tissue injury

  • Immunomodulation: Investigated for its role in cytokine balance and immune cell response


⚠️ Disclaimer: ARA-290 is intended for laboratory research use only. It is not for human consumption, not for diagnostic or therapeutic use, and has not been evaluated by the FDA or other regulatory agencies for clinical application. Use only under appropriate institutional research protocols and biosafety guidelines.

Availability: In stock (can be backordered)

Guaranteed Safe Checkout
  • No-Risk Money Back Guarantee!
  • Secure Payments

Introduction to ARA-290

ARA-290 is a synthetic peptide derived from erythropoietin (EPO), designed for preclinical research exploring cellular signaling pathways involved in inflammation, tissue repair, and metabolic regulation. It has been investigated in non-human models for its potential role in modulating immune responses, neuropathic mechanisms, and glucose-related biomarkers.


Mechanism of Action (Research-Based)

In experimental models, ARA-290 interacts with tissue-protective receptors (TPRs)—a non-erythropoietic receptor complex expressed on immune cells such as macrophages, mast cells, dendritic cells, and lymphocytes. This interaction has been associated with:

  • Reduced release of pro-inflammatory cytokines (e.g., IL-6)

  • Improved cellular resilience in inflammatory conditions

  • Preservation of islet cell viability, which plays a key role in glycemic regulation studies

  • Neuroprotective signaling, potentially supporting pain modulation and nerve recovery models


Key Research Areas (Preclinical Use Only)

ARA-290 is under investigation in in vitro and animal models in the following research domains:

  • Metabolic Studies: Evaluated for effects on glucose regulation and lipid profiles

  • Neuropathic Pain Models: Studied for modulation of pain signaling pathways in experimental neuropathy

  • Inflammatory Regulation: Explored for anti-inflammatory signaling via TPR interaction

  • Tissue Repair & Wound Healing: Assessed in models of skin and soft tissue injury

  • Immunomodulation: Investigated for its role in cytokine balance and immune cell response


⚠️ Disclaimer: ARA-290 is intended for laboratory research use only. It is not for human consumption, not for diagnostic or therapeutic use, and has not been evaluated by the FDA or other regulatory agencies for clinical application. Use only under appropriate institutional research protocols and biosafety guidelines.

Certificate of Analysis

ARA-290 10mg – COA – FYP

PropertyDescription
Chemical SequenceAla-Glu-Asp-Leu
CAS158152-06-2
Molecular FormulaC17H29N5O6
Molecular WeightApproximately 403.44 g/mol
AppearanceWhite Lyophilized Powder

Research Use Only:

ARA-290 is intended strictly for in vitro testing and laboratory experimentation. It is not intended for human or animal medical use. It is not a drug, food, or cosmetic and should not be misbranded, misused, or mislabeled as such

You may also like…

Shopping Cart
ARA-290 10mgARA-290 10mg
Original price was: $34.99.Current price is: $29.99.

Availability: In stock (can be backordered)